检索

期
标题
作者
卷 94, 编号 2 (2022)
The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus
Maev I., Mkrtumyan A., Bektemirova L., Andreev D., Dicheva D.
PDF
(Rus)
卷 90, 编号 8 (2018)
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection
Yurenev G., Partzvania-Vinogradova E., Andreev D., Dicheva D., Maiev I.
PDF
(Rus)
卷 91, 编号 8 (2019)
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease
Veliev A., Maev I., Andreev D., Dicheva D., Zaborovskii A., Lobanova E., Bektemirova L.
PDF
(Rus)
卷 86, 编号 1 (2014)
The course of coronary heart disease concurrent with peptic ulcer disease: Clinical and pathogenetic aspects
Simonova Z., Martusevich A., Tarlovskaia E.
卷 93, 编号 8 (2021)
A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of Helicobacter pylori infection with the inclusion of the probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68
Yakovenko E., Strokova T., Iakovenko A., Ivanov A., Soluyanova I., Vasilyev N.
PDF
(Rus)
卷 89, 编号 8 (2017)
Analysis of the clinical efficiency of eradication therapy in patients with coronary heart disease associated with gastroduodenal pathology
Simonova Z., Martusevich A., Tarlovskaya E.
PDF
(Rus)
卷 93, 编号 2 (2021)
Efficacy of butyric acid inclusion in eradication regimens for Helicobacter pylori infection: a meta-analysis of controlled trials
Andreev D., Kucheryavyy Y., Maev I.
PDF
(Rus)
卷 89, 编号 8 (2017)
Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy
Maev I., Andreev D.
PDF
(Rus)
卷 92, 编号 11 (2020)
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years
Andreev D., Maev I., Kucheryavyy Y.
PDF
(Rus)
卷 89, 编号 2 (2017)
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice
Andreev D., Dicheva D., Maev I.
PDF
(Rus)
卷 92, 编号 8 (2020)
European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan
Abdulkhakov S., Bordin D., Abdulkhakov R., Safina D., Gizdatullina A., Gimadieva L., Safina G., Ziyatdinov A., Maturina A., Nyssen O., Megraud F., O’Morain C., Perez-Gisbert J.
PDF
(Rus)
卷 88, 编号 12 (2016)
Use of probiotics and probiotic-based immunomodulators as adjuvant therapy for Helicobacter pylori eradication
Konorev M., Andronova T., Matveenko M.
PDF
(Rus)
卷 92, 编号 8 (2020)
Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results
Maev I., Andreev D., Govorun V., Ilina E., Kucheryavyy Y., Oganesian T., Melnikova E., Zayratyants O., Parfenova T., Dzhedzheia L., Kirillova N., Maevskaya E., Fomenko A., Lobanova E., Zaborovskii A., Kriukov K.
PDF
(Rus)
卷 86, 编号 12 (2014)
Antiplatelet therapy with acetylsalicylic acid: Approaches to reducing the frequency of gastrointenstinal adverse reactions
Onuchina E.
卷 91, 编号 8 (2019)
Underwater rocks of anti - helicobacter therapy
Livzan M.
PDF
(Rus)
卷 86, 编号 8 (2014)
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases
Samsonov A., Grechushnikov V., Andreev D., Iurenev G., Korovina T., Lezhneva I., Maev I.
1 - 16 的 16 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##